Form 4: Novanta CEO Sells 7,500 Shares Under 10b5-1 Plan

Novanta Inc. CEO Matthijs Glastra sold 7,500 shares of common stock for $145.04 per share, executed under a pre-established Rule 10b5-1 trading plan.

Summary

• Matthijs Glastra, Chief Executive Officer and Director of Novanta Inc. (NOVT), sold 7,500 shares of the company's common stock.
• The transaction occurred on February 10, 2026, at a weighted-average price of $145.04 per share, with individual trades ranging from $145.00 to $145.44.
• The sale was conducted pursuant to a pre-established Rule 10b5-1 trading plan, which was adopted on September 11, 2025.
• The shares were sold through a trust for which Mr. Glastra's spouse serves as a trustee.
• Following this transaction, Mr. Glastra directly beneficially owns 57,367 shares and indirectly beneficially owns 54,382 shares through the Matthijs Glastra 2021 Irrevocable Trust.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, typical for executive financial planning under a pre-arranged 10b5-1 plan, and not necessarily a signal of management's view on the company's immediate prospects.

Future Outlook

No forward-looking statements or guidance are provided in this Form 4 filing, which is solely for reporting an insider transaction.

Management Comments

• The sales reported were effected pursuant to a pre-established Rule 10b5-1 trading plan that was adopted on September 11, 2025, through a trust for which the reporting person's spouse is a trustee.

Industry Context

StockSavvy.ai notes that insider sales executed under Rule 10b5-1 trading plans are a common practice for executives to manage personal financial planning and diversify their portfolios. These pre-scheduled transactions are designed to avoid concerns about trading on material non-public information and are generally considered routine disclosures within the industry.

Related Party Transactions

• The sale was conducted through a trust for which the reporting person's spouse is a trustee, indicating a related party transaction.

Stakeholder Impact

• Shareholders will note the insider sale, but the execution under a Rule 10b5-1 plan typically mitigates concerns that the sale is based on new, negative information about the company's performance.

Key Dates

Recommendation

The transaction is a pre-planned insider sale under a Rule 10b5-1 plan, which is a routine event for executive financial management and does not typically signal a change in the company's fundamentals or future outlook. Therefore, it does not warrant a change in investment recommendation based solely on this filing.

Keywords

Novanta Inc., NOVT, Matthijs Glastra, Insider Sale, Form 4, Rule 10b5-1, CEO, Stock Transaction, Equity Sale